Merck Price Target Cut to $145.00/Share From $150.00 by B of A Securities
Merck & Co Analyst Ratings
UBS Maintains Buy on Merck & Co, Lowers Price Target to $142
Morgan Stanley Maintains Merck & Co(MRK.US) With Hold Rating, Cuts Target Price to $130
Evercore Maintains Merck & Co(MRK.US) With Buy Rating
BofA Securities Initiates Merck & Co(MRK.US) With Buy Rating
A Quick Look at Today's Ratings for Merck & Co(MRK.US), With a Forecast Between $125 to $150
Merck & Company (MRK) Gets a Hold From Morgan Stanley
Buy Rating on Merck & Co. Amid Temporary Setbacks and Strong Growth Outlook
Wells Fargo Adjusts Price Target on Merck & Co. to $125 From $140, Maintains Equalweight Rating
Evercore Initiates Merck & Co(MRK.US) With Buy Rating
Merck & Co. Poised for Growth: Strong Q2 Performance and Promising Pipeline Fuel Buy Rating
BMO Capital Adjusts Price Target on Merck to $150 From $148
TD Cowen Adjusts Price Target on Merck to $140 From $135
Goldman Sachs Adjusts Price Target on Merck & Company to $145 From $144
Merck & Co Analyst Ratings
Morgan Stanley Adjusts Price Target on Merck to $134 From $132
Merck & Co Analyst Ratings
HSBC Adjusts Price Target on Merck & Co. to $130 From $118, Keeps Hold Rating
Merck & Co Analyst Ratings